Abstract
Background: Population-based studies on patients with rheumatoid arthritis support a negative
association between dementia due to Alzheimer's disease (DAT) and rheumatoid arthritis
(RA). Several workers have suggested that inheritance of the apolipoprotein E (ApoE)
e4 allele is a risk factor for developing DAT. In addition, earlier studies have suggested
that ApoE e2 is under-represented in DAT, suggesting that it is a negative risk factor.
Methods: To determine whether the distribution of the various isoforms of ApoE e2, in particular,
could explain the low prevalence of DAT in the RA population, we carried out ApoE
genotyping in 180 DAT patients, 75 RA patients, and 53 healthy controls. The ApoE
e allele was determined by polymerase chain reaction. Results: There was no significant difference between the control group and the RA group in
the distribution of the various alleles, in particular ApoE e2. The phenotype most
frequently found in all three groups was Apo E3/E3. The ApoE3/E4 phenotype was much
more frequent in the DAT group than in the RA group or in controls. The ApoE e4 allele
was significantly more frequent in patients with Alzheimer's disease than in the other
groups. Conclusions: Our results suggest that the presence of the Apo e2 allele is not what protects
the RA patient from DAT.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Internal MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Diagnosis and treatment of Alzheimer disease and related disorders.JAMA. 1997; 278: 1363-1371
- Neuroimmune mechanisms in Alzheimer disease pathogenesis.Alzheimer Dis. Assoc. Disord. 1994; 8: 149-165
- Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late onset familial Alzheimer disease.Proc. Natl. Acad. Sci. U.S.A. 1993; 90: 1977-1981
- Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer's disease.Neurology. 1993; 43: 1467-1472
- Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease.Hum. Mol. Genet. 1994; 3: 569-574
- Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis.JAMA. 1997; 278: 1349-1356
- Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease.Nat. Genet. 1994; 7: 180-184
- Apolipoprotein E alleles as risk factors in Alzheimer disease.Annu. Rev. Med. 1996; 47: 387-400
- Anti-inflammatory drugs and Alzheimer disease.Lancet. 1990; 335: 1037
- Alzheimer's disease and rheumatoid arthritis.Br. J. Rheumatol. 1994; 33: 501-502
- Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies.Neurology. 1996; 47: 425-432
- Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task force on Alzheimer's disease.Neurology. 1984; 34: 939-944
- The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.Arthritis Rheum. 1988; 31: 315-324
- A simple salting out procedure for extracting DNA from human nucleated cells.Nucleic Acids Res. 1988; 16: 1215
- Restriction isotyping of human apolipoprotein E by gene amplification and cleavage HhaI.J. Lipid Res. 1990; 31: 545-548
- Apolipoprotein E: cholesterol transport protein with expanding role in cell biology.Science. 1988; 240: 622-630
- Isoform-specific interactions of apolipoprotein E with microtubule associated protein tau: implications for Alzheimer's disease.Proc. Natl. Acad. Sci. U.S.A. 1994; 91: 1183-1186
- Inflammatory processes and anti-inflammatory drugs in Alzheimer's disease: a current apraisal.Neurobiol. Aging. 1996; 17: 789-794
- Non-steroidal anti-inflammatory drug use and Alzheimer-type pathology in aging.Neurology. 1998; 50: 986-990
- High prevalence of serum apolipoprotein E4 isoprotein in rheumatoid arthritis patients with amyloidosis.Arthritis Rheum. 1996; 39: 1728-1732
- Genetic epidemiology of Alzheimer disease.Epidemiol. Rev. 1997; 19: 107-119
- HLA-DR antigens associated with major risk for late-onset Alzheimer's disease.NeuroReport. 1997; 8: 1467-1469
- HLA-DR alleles with naturally occurring amino acid substitutions and risk for development of rheumatoid arthritis.Arthritis Rheum. 1990; 33: 939-946
Article info
Publication history
Accepted:
April 20,
1999
Received in revised form:
April 13,
1999
Received:
March 23,
1999
Identification
Copyright
© 1999 Elsevier Science B.V. Published by Elsevier Inc. All rights reserved.
